What Is aTyr Pharma, Inc. (ATYR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, aTyr Pharma, Inc. presents a highly debated valuation profile at its current price of $0.53. The composite intrinsic value is estimated at $0.50 (-6.3% average upside), masking a wide model spread between the 3 bullish models and 4 bearish models. Model dispersion is worth noting: Dynamic NAV targets $1.34 (+151.0%), versus Regime Cross at $0.01 (-98.1%). This +249.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ATYR?
9 of 13 models are currently active for ATYR. Of these, 5 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates ATYR's intrinsic value at $0.18, implying -65.9% downside from the current price. See which stocks rank higher →
How Does ATYR Rank in Biotechnology?
Among 76 Biotechnology stocks, ATYR ranks #37 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
aTyr Pharma, Inc.'s positioning within the Biotechnology segment means that R&D burn rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including platform technology validation — shape both the opportunity set and risk profile.
Is ATYR a Value Trap?
CirclFi's Value Trap algorithm assigns ATYR a score of 51/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for aTyr Pharma, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, aTyr Pharma, Inc. earns a quality score of 5.0/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.
The gap between the most bullish and bearish model spans +249.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ATYR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ATYR's 9 active models, average confidence is 22%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad